Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl Turesson

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
Swiss Medical Weekly|April 6, 2016
Comorbidity in rheumatoid arthritisCarl Turesson
Current Opinion in Rheumatology|February 22, 2013
Extra-articular rheumatoid arthritisCarl Turesson
Current Pharmaceutical Design|February 3, 2004
Endothelial expression of MHC class II molecules in autoimmune diseaseCarl Turesson
Annals of the Rheumatic Diseases|October 8, 2014
The impact of obesity on the development and progression of rheumatoid arthritisAxel Finckh, Carl Turesson
The Journal of Rheumatology|September 1, 2004
Septicemia with Staphylococcus aureus, beta-hemolytic streptococci group B and G, and Escherichia coli in a patient with rheumatoid arthritis treated with a recombinant human interleukin 1 receptor antagonist (Anakinra)Carl Turesson, Kristian Riesbeck
Mayo Clinic Proceedings|January 28, 2006
Genetics of rheumatoid arthritisCarl Turesson, Eric L Matteson
Arthritis and Rheumatism|April 1, 2006
Is atherosclerosis in rheumatoid arthritis related to disease severity and extraarticular manifestations? Comment on the article by Chung et alCarl Turesson, Eric L Matteson
Current Opinion in Rheumatology|December 17, 2008
Vasculitis in rheumatoid arthritisCarl Turesson, Eric L Matteson
Current Opinion in Rheumatology|April 23, 2004
Management of extra-articular disease manifestations in rheumatoid arthritisCarl Turesson, Eric L Matteson
Arthritis and Rheumatism|May 18, 2004
Signs of systemic disease are strong determinants of mortality in rheumatoid arthritis: comment on the article by Navarro-Cano et alCarl Turesson, Eric L Matteson
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Swiss Medical Weekly|April 6, 2016
Comorbidity in rheumatoid arthritisCarl Turesson
Current Opinion in Rheumatology|February 22, 2013
Extra-articular rheumatoid arthritisCarl Turesson
Current Pharmaceutical Design|February 3, 2004
Endothelial expression of MHC class II molecules in autoimmune diseaseCarl Turesson
Annals of the Rheumatic Diseases|October 8, 2014
The impact of obesity on the development and progression of rheumatoid arthritisAxel Finckh, Carl Turesson
The Journal of Rheumatology|September 1, 2004
Septicemia with Staphylococcus aureus, beta-hemolytic streptococci group B and G, and Escherichia coli in a patient with rheumatoid arthritis treated with a recombinant human interleukin 1 receptor antagonist (Anakinra)Carl Turesson, Kristian Riesbeck
Mayo Clinic Proceedings|January 28, 2006
Genetics of rheumatoid arthritisCarl Turesson, Eric L Matteson
Arthritis and Rheumatism|April 1, 2006
Is atherosclerosis in rheumatoid arthritis related to disease severity and extraarticular manifestations? Comment on the article by Chung et alCarl Turesson, Eric L Matteson
Current Opinion in Rheumatology|December 17, 2008
Vasculitis in rheumatoid arthritisCarl Turesson, Eric L Matteson
Current Opinion in Rheumatology|April 23, 2004
Management of extra-articular disease manifestations in rheumatoid arthritisCarl Turesson, Eric L Matteson
Arthritis and Rheumatism|May 18, 2004
Signs of systemic disease are strong determinants of mortality in rheumatoid arthritis: comment on the article by Navarro-Cano et alCarl Turesson, Eric L Matteson
Pageof 14